You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 201891 - 201900 of 207699 results
  1. Augmented Reality Head Mounted Display for Magnetic Resonance Imaging Guided Inte

    SBC: PERCEPTIMED, INC.            Topic: NINR

    DESCRIPTION (provided by applicant): Medication errors are one of the most prevalent patient safety issues in long term care facility quality. The widespread adoption of electronic prescribing systems and electronic medication administration records (eMAR)has opened the door for the development and deployment of new technologies to address errors occurring in the administration of medications. Ide ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  2. Chloroquine Sensitive Plasmodium falciparum for MultiValent Vaccine and Challenge

    SBC: Simbex LLC            Topic: NINR

    DESCRIPTION (provided by applicant): The Principal Objective of this Fast Track SBIR project is to develop and validate a cost-effective commercial product, TheraSense , a highly innovative active support surface bed system for the treatment and prevention of serious decubitus ulcers, commonly known as bed sores or pressure ulcers. Current advanced bed systems for both institutional and home ther ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  3. Mobile Motivation for Health Promotion Among Adolescents

    SBC: ADVANCED MRI TECHNOLOGIES LLC            Topic: NINDS

    DESCRIPTION (provided by applicant): MRI cerebral perfusion imaging is a widely disseminated technique on nearly all MRI scanners used for clinical diagnosis of brain disease and for neuroscience research. Over the last five years there has been considerably increased use of arterial spin labeling (ASL) for clinical diagnosis, while still i.v. injections of a gadoliium based contrast bolus are wid ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  4. Label-free platform for applications in drug discovery

    SBC: SENSIQ TECHNOLOGIES, INC.            Topic: NCATS

    DESCRIPTION: Incremental improvements in label free screening technologies over the past decade have not produced the capability necessary to support the changing needs of drug discovery programs. Persistent artifacts related to non-specific binding, promiscuous binding, precipitation, complex binding, tubing retention, aggregation, and sub-optimally designed platforms continue to hinder progress ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  5. Targeted Docetaxel-Nanocolloid for the Treatment of Ovarian Cancer

    SBC: NEMUCORE MEDICAL INNOVATIONS, INC.            Topic: NCI

    DESCRIPTION (provided by applicant): PROJECT SUMMARY This proposal is a Phase 1 proposal in response to The National Institute of Health Small Business Innovation Research (SBIR) Program call for proposals for the Cancer Diagnostics and Therapeutic AgentsEnabled By Nanotechnology (SBIR [U43/U44]) [Program Announcement Number: PA-10-286]. Nemucore Medical Innovation, Inc.'s (NMI) goal for thi ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  6. Aluminum Oxide Nanoparticles Conjugated to Antigens Potently Induce Tumor Specifi

    SBC: UBIVAC, LLC            Topic: NCI

    DESCRIPTION (provided by applicant): PROJECT SUMMARY Although prophylactic vaccines have potential for prevention of high risk human papilloma virus (HPV) infection they have no therapeutic efficacy. It has been estimated that there will be no measurable decline of HPV- associated tumors before 2040 (Hellner et al., 2011). Likewise, other HPV-associated angogenital and head and neck cancers are pr ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  7. Targeted nanoparticle gene therapy for lung cancer

    SBC: SAVARA INC.            Topic: NCI

    DESCRIPTION (provided by applicant): Project Summary A transformational NanoNucleic delivery technology is being investigated by Savara Inc. as a promising first-in-class gene therapy candidate for lung cancer. A potent lung cancer therapy with fewer sideeffects is urgently needed due to the exceptionally high rates of morbidity and mortality of this particular cancer. Gene therapy, while promisin ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  8. Development of an Implantable Trigeminal Nerve Stimulation System for Drug Resist

    SBC: NeuroSigma, Inc.            Topic: NINDS

    DESCRIPTION (provided by applicant): Epilepsy affects three million Americans and fifty million people worldwide. Drug resistant epilepsy (DRE) affects over one third of all people with epilepsy, and may lead to unemployment, injury, and death. TrigeminalNerve Stimulation (TNS) is an emerging neuromodulation therapy for DRE, which has unique advantages over other techniques. TNS can be delivered b ...

    SBIR Phase I 2013 Department of Health and Human ServicesNational Institutes of Health
  9. CBT Supervisor's Toolkit: Phase II

    SBC: CBT4CBT LLC            Topic: NIAAA

    DESCRIPTION (provided by applicant): ABR's recent series of innovative randomized trials evaluating the efficacy of various strategies for training clinicians to use evidence based therapies in alcohol and drug abuse has indicated that while both in-personworkshop and computer-assisted training can impart the skills necessary to deliver Cognitive Behavioral Therapy (CBT), they are not suffici ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
  10. High throughput tau oligomer drug screening assay for Alzheimer's disease

    SBC: OLIGOMERIX INC            Topic: NIA

    DESCRIPTION (provided by applicant): There is a very large and rapidly growing unmet need for disease-modifying drugs for Alzheimer's disease (AD) as its prevalence is increasing worldwide due to demographic shifts in the aging population. AD is the thirdmost costly disease in the US with direct costs over 200 billion annually. The proposed phase IIB program is for the continued development ...

    SBIR Phase II 2013 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government